medical-device-investing Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
medical-device-investing Study of Medtronic Hugo robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
medical-device-investing FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
medical-device-investing Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
medical-device-investing Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
medical-device-investing Medtronic to announce financial results for its first quarter of fiscal year 2026
medical-device-investing Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
medical-device-investing Medtronic secures CE Mark for MiniMed 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
medical-device-investing Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
medical-device-investing Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
medical-device-investing Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
